Community Health Systems, Inc.

NYSE:CYH

Medical - Care Facilities

Healthcare
$1.86 +1.50%

+$0.05 today

Market cap
$262.31M
Beta
1.86
P/E (TTM)
-4.6
EPS (TTM)
-$0.66
52W Low $2.38High $4.43

Volume 2.88M

Average 1.61M

CYH Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Community Health Systems, Inc.NYSE: CYH

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How CYH compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Research & development amounts to 0.0% of revenue for CYH, versus a peer median of 1.6%.
CYH Competitors
Research & Development for CYH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FDMT4D Molecular Therapeutics, Inc.LTM Mar 2026$219.98M USD+42.7%+34.6%249.3%
CMPSCOMPASS Pathways plcLTM Mar 2026$110.07M USD-12.0%+22.1%—
VREXVarex Imaging CorporationLTM Apr 2026$89.5M USD+0.1%+5.8%10.4%
AVNSAvanos Medical, Inc.LTM Mar 2026$22.9M USD-6.9%-8.9%3.2%
TALKTalkspace, Inc.LTM Mar 2026$11.72M USD+17.1%-23.9%4.9%
CYHCommunity Health Systems, Inc.LTM Mar 2026$0 USD——0.0%
SNDASonida Senior Living, Inc.LTM Mar 2026$0 USD——0.0%
INNVInnovAge Holding Corp.LTM Mar 2026$0 USD——0.0%
TOIThe Oncology Institute, Inc.LTM Mar 2026$0 USD——0.0%
AUNAAuna S.A.LTM Mar 2026PEN 0 PEN——0.0%
Peer median (excluding CYH) —+0.1%+5.8%1.6%

Competitors are the stored peer set for CYH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue12.37B12.21B12.49B12.63B12.49B
Cost of Revenue7.28B7.31B7.41B7.36B11.4B
Gross Profit5.08B4.91B5.08B5.27B1.08B
Gross Margin41.1%40.2%40.7%41.7%8.7%
Research & Development108M85M80M00
Selling, General & Admin308M317M319M299M0
Operating Expenses3.68B4.09B4.13B4.73B11B
Depreciation & Amortization432M449M425M406M426M
EBITDA1.71B1.17B1.3B1.25B2.02B
EBITDA Margin13.8%9.6%10.4%9.9%16.2%
Operating Income1.4B821M957M542M(9.92B)
Operating Margin11.3%6.7%7.7%4.3%-79.4%
Interest Income002M3M0
Interest Expense885M858M832M863M870M
Other Income / Expenses(903M)(472M)(750M)(825M)10.64B
Income Before Tax499M349M207M(283M)724M
Pre-Tax Margin4.0%2.9%1.7%-2.2%5.8%
Income Tax Expense131M170M191M79M48M
Net Income230M46M(133M)(516M)509M
Net Margin1.9%0.4%-1.1%-4.1%4.1%
EPS (Basic)1.820.36(1.02)(3.90)3.80
EPS (Diluted)1.760.35(1.02)(3.90)3.77
Weighted Avg Shares126.75M128.81M130.39M132.1M134M
Weighted Avg Shares (Diluted)130.6M130.06M130.45M132.1M135M

Community Health Systems, Inc.

NYSE:CYH

Intrinsic Alpha fair value

Locked

Current Price

$1.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.